Deepanshu Saini, Director of Program Management at IQVIA reflects on the interplay between safety and AI pharmacovigilance.

The FDA will require pharmaceutical companies to study whether their opioid products are effective treatments for chronic pain, reports The Washington Post. While some studies show opioids are ...

Opioid medications will now be required to have updated warning labels and safety information, according to a new mandate from the FDA. The requirements also extend to medication guides to provide ...

The Food and Drug Administration is attempting to put a spotlight on the potential risks associated with prolonged use of opioid pain medications by mandating changes to the way those products are ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Originally established in 1938 and expanded in 1962, the FDA’s mandate has been to determine ...

The Food and Drug Administration (FDA) had rescinded emergency use authorizations (EUAs) for COVID-19 vaccines, Health and Human Services Secretary Robert F. Kennedy Jr. announced Wednesday, saying ...

The US Food and Drug Administration (FDA) has published its long-awaited assessment of per- and polyfluoroalkyl substances (PFAS) in cosmetic products, highlighting significant data gaps around their ...

In the current Cyber Threat environment, companies must have strong cyber liability insurance. Policies must specifically account for cyber-physical risks and the substantial costs of post-market ...